BioAge is a clinical-stage biotechnology company that develops drugs to treat aging and aging-related diseases.
View all
Voyager Therapeutics
Cambridge, United States · Post IPO Equity
Volastra
Boston, United States · Series A
Aspen Neuroscience
San Diego, United States · Debt Financing
AllStripes
San Francisco, United States · Series B
Mission Bio
San Francisco, United States · Series C
Korro Bio
Cambridge, United States · Series B
Illumina
San Diego, United States
MassBio
Cambridge, United States
CytomX
South San Francisco, United States
Axsome Therapeutics
New York, United States · Post IPO Equity
Cue Biopharma
Cambridge, United States · Post IPO Equity
Allakos
San Carlos, United States · Post IPO Equity